Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.
暂无分享,去创建一个
[1] M. Geiser,et al. Chaperone over-expression in Escherichia coli: apparent increased yields of soluble recombinant protein kinases are due mainly to soluble aggregates. , 2009, Protein expression and purification.
[2] Leyu Wang,et al. High yield expression of non-phosphorylated protein tyrosine kinases in insect cells. , 2008, Protein expression and purification.
[3] P. Chène. Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases. , 2008, Drug discovery today.
[4] D. Fairlie,et al. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. , 2007, Drug discovery today.
[5] D. M. Penny,et al. Mouse Aurora A: expression in Escherichia coli and purification. , 2007, Protein expression and purification.
[6] Catherine K. Smith,et al. Expression and purification of phosphorylated and non-phosphorylated human MEK1. , 2007, Protein expression and purification.
[7] D. Wasilko,et al. TIPS: Titerless Infected-Cells Preservation and Scale-Up , 2006 .
[8] J. Mestan,et al. Allosteric inhibitors of Bcr-abl–dependent cell proliferation , 2006, Nature chemical biology.
[9] J. Kuriyan,et al. High yield bacterial expression of active c‐Abl and c‐Src tyrosine kinases , 2005, Protein science : a publication of the Protein Society.
[10] P. Lemotte,et al. Phosphorylation of serine residues in histidine-tag sequences attached to recombinant protein kinases: a cause of heterogeneity in mass and complications in function. , 2005, Protein expression and purification.
[11] T. Mohanakumar,et al. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. , 2004, Human immunology.
[12] D. Fabbro,et al. In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. , 2004, Cancer cell.
[13] E. Sausville,et al. Issues and progress with protein kinase inhibitors for cancer treatment , 2003, Nature Reviews Drug Discovery.
[14] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[15] P. Cohen. Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.
[16] Stevan R. Hubbard,et al. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase , 2001, Nature Structural Biology.
[17] H. Nielsen,et al. Loss of ELISA specificity due to biotinylation of monoclonal antibodies. , 2000, Journal of immunological methods.
[18] A. Chapman-Smith,et al. In vivo enzymatic protein biotinylation. , 1999, Biomolecular engineering.
[19] A. Chapman-Smith,et al. The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. , 1999, Trends in biochemical sciences.
[20] J. Mccoy,et al. A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli. , 1998, Nucleic acids research.
[21] G. Kulik,et al. Src Phosphorylates the Insulin-like Growth Factor Type I Receptor on the Autophosphorylation Sites , 1996, The Journal of Biological Chemistry.
[22] T. Zor,et al. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. , 1996, Analytical biochemistry.
[23] C. S. Zong,et al. Effect of Tyrosine Mutations on the Kinase Activity and Transforming Potential of an Oncogenic Human Insulin-like Growth Factor I Receptor (*) , 1996, The Journal of Biological Chemistry.
[24] C. Kahn,et al. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation. , 1994, The Journal of biological chemistry.
[25] C. Kahn,et al. The insulin signaling system. , 1994, The Journal of biological chemistry.
[26] P. Schatz. Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli , 1993, Bio/Technology.
[27] J. C. Clemens,et al. The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage , 1992, The Journal of experimental medicine.
[28] J. C. Clemens,et al. Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase. , 1992, The Journal of biological chemistry.
[29] J. Dixon,et al. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. , 1990, Science.
[30] J. Cronan. Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins. , 1990, The Journal of biological chemistry.
[31] N. Gray,et al. Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.
[32] Jeffrey Jie-Lou Liao,et al. Targeting protein multiple conformations: a structure-based strategy for kinase drug design. , 2007, Current topics in medicinal chemistry.
[33] Ville Santala,et al. Production of a biotinylated single-chain antibody fragment in the cytoplasm of Escherichia coli. , 2004, Journal of immunological methods.